SAN FRANCISCO and TEL AVIV, Israel, Oct. 02, 2019 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the “Company” or “Kalytera“) is pleased to announce that the European Patent Office has issued a Notice of Allowance for EU Patent Application Number 14791611.8 covering the use of cannabidiol (“CBD”) in the treatment […]
Category Archives: Public Companies
PFSweb to Present at the 5th Annual B. Riley FBR Consumer & Media Conference
ALLEN, Texas, Oct. 02, 2019 (GLOBE NEWSWIRE) — PFSweb, Inc. (NASDAQ: PFSW), a global commerce services company, will be presenting at the 5th Annual B. Riley FBR Consumer & Media Conference, which is being held on Thursday, October 3, 2019 at the Sofitel Hotel in New York City. PFSweb management is scheduled to present at […]
Trakopolis Announces Expiry of Amendment Agreement with Lender and Potential Covenant Non-Compliance
CALGARY, Alberta, Oct. 02, 2019 (GLOBE NEWSWIRE) — Trakopolis IoT Corp. (TSXV: TRAK) (“Trakopolis” or the “Company“) today announces that, further to its press release dated August 2, 2019 (the “Prior Release“), the amending agreement (the “Amending Agreement“) entered into between the Company and its lender, ESW Holdings, Inc. (the “Lender“) has expired, rendering the […]
CellaVision completes the acquisition of RAL Diagnostics
The information was released for public disclosure on October 2, 2019, at 14:30 CET CellaVision has completed the previously announced acquisition of RAL Diagnostics, a company focused on the production and sale of products for sample preparation in hematology, pathology, cytology and microbiology. RAL Diagnostics complements CellaVision’s products very well in hematology and the acquisition […]
CellaVision slutför förvärvet av RAL Diagnostics
Informationen lämnades för offentliggörande 2019-10-02 kl. 14:30 CellaVision har slutfört det tidigare aviserade förvärvet av RAL Diagnostiscs, ett bolag inriktat på produktion och försäljning av provberedningsprodukter inom hematologi, patologi, cytologi och mikrobiologi. RAL Diagnostics kompletterar CellaVisions produkter mycket väl inom hematologi och förvärvet ses som strategiskt viktigt på såväl kort som lång sikt. RAL Diagnostics […]
Copenhagen Capital A/S – Indberetning i henhold til § 29 – Storaktionærmeddelelse
I henhold til § 29 i lov om værdipapirhandel har Copenhagen Capital A/S modtaget meddelelse om, at Atlas Equity ApS med nærtstående via selskabets udstedes af nye præferenceaktier har ændret den samlede ejerandel i Copenhagen Capital A/S. Atlas Equity ApS med nærtstående ejer herefter mindre end 10,00 % af den nominelle aktiekapital i selskabet. Atlas Equity […]
Skeljungur hf.: P/F Magn wins tender and anticipates in cooperation to construct and operate a windmill park in the Faroe Islands
Orka, the Faroese electricity authority, has approved an offer from a special purpose vehicle (“SPV”), established by P/F Magn, the Faroese subsidiary of Skeljungur hf, to have license to build and operate a windmill park in Flatnahagi, Faroe Islands, and to purchase the energy that will be produced there. The offer is subject to number of […]
Skeljungur hf.: P/F Magn vann útboð og stefnir að uppbyggingu vindmyllna í Færeyjum í samstarfi við þarlenda lífeyrissjóði
Færeyska raforkustofnunin, Orka, samþykkti í dag tilboð sem dótturfélag Skeljungs í Færeyjum, P/F Magn, lagði inn fyrir hönd óstofnaðs félags um leyfi til uppbyggingar og rekstur vindmylla á landsvæði sem nefnist Flatnahagi, í Færeyjum, og kaup á þeirri orku sem framleidd verður þar. Tilboðið er gert með nokkrum fyrirvörum, m.a. um samþykki stjórnar og fullnægjandi […]
Copenhagen Capital A/S – Indberetning i henhold til § 29 – Storaktionærmeddelelse
I henhold til § 29 i lov om værdipapirhandel har Copenhagen Capital A/S modtaget meddelelse om, at Hans August Lund med nærtstående via køb af præferenceaktier i selskabet har ændret den samlede ejerandel i Copenhagen Capital A/S. Hans August Lund med nærtstående ejer herefter 2.275.000 stk. stamaktier og 2.857.143 stk. præferenceaktier i Copenhagen Capital A/S. Den […]
Juggernaut Announces Share Consolidation
VANCOUVER, British Columbia, Oct. 02, 2019 (GLOBE NEWSWIRE) — Juggernaut Exploration Ltd. (TSX-V: JUGR) (OTCQB: JUGRF) (FSE: 4JE) (the “Company” or “Juggernaut”) announces its intention to consolidate its common shares (“Shares”) on a 10-old-for-1-new share basis (the “Consolidation”). The 105,225,564 Shares currently issued and outstanding will be reduced to approximately 10,522,556 post-Consolidation Shares. No fractional […]